as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
3.64%
Downside
3.31%
Upside
52 Week's Low
52 Week's High
65.23%
Downside
12.58%
Upside
Check Taysha Gene Therapies Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$837.5M
EPS (TTM)
-0.322
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.85
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
0EBITDA
-88.0M
Revenue (TTM)
8.1M
Profit Margin
0.00%
Return On Equity TTM
139772900.00%
Track how Taysha Gene Therapies Inc P/E has moved over time to understand its valuation trends.
Taysha Gene Therapies Inc in the last 5 years
Lowest (3.33x)
September 30, 2024
Today (-3.85x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Highest (15.33x)
December 31, 2023
Today’s Price to Earnings Ratio: -3.85x
Compare market cap, revenue, PE, and other key metrics of Taysha Gene Therapies Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $837.5M | NA | -3.85 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Taysha Gene Therapies Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Taysha Gene Therapies Inc investment value today
Current value as on today
₹1,36,863
Returns
₹36,863
(+36.86%)
Returns from Taysha Gene Therapies Inc Stock
₹31,878 (+31.88%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Taysha Gene Therapies Inc. Average target price of $8.67
Get share price movements and forecasts by analysts on Taysha Gene Therapies Inc.
What analysts predicted
65.17%UPSIDE
Target Price
$8.67
Current Price
$3.02
Analyzed by
16 Analysts
Target
$8.67
Taysha Gene Therapies Inc target price $8.67, a slight upside of 65.17% compared to current price of $3.02. According to 16 analysts rating.
Search interest for Taysha Gene Therapies Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 41.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 124.8%
Price Dip
In the last 7 days, TSHA stock has moved down by -5.2%
Organisation | Taysha Gene Therapies Inc |
Headquarters | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Industry | Health Technology |
CEO | Mr. Sean P. Nolan |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Kamran Alam CPA, M.B.A. | CFO & Corporate Secretary |
Ms. Tracy M. Porter SPHR | Chief People Officer |
Ms. Emily McGinnis M.P.H. | Chief Patient & External Affairs Officer |
Mr. Frederick Porter Ph.D. | Chief of Staff & Technical Operations Officer |
Mr. Sean McAuliffe | Chief Business Officer |
Dr. Steven Gray Ph.D. | Chief Scientific Advisor of UT Southwestern Gene Therapy Program |
Berge Minassian M.D. | Chief Medical Advisor of UT Southwestern Gene Therapy Program |
Mr. Sean P. Nolan | CEO & Chairman |
Dr. Sukumar Nagendran M.D. | President, Head of Research & Development and Director |
Hayleigh Collins | Director of Corporate Communications & Investor Relations |
Taysha Gene Therapies Inc share price today is $3.02 as on at the close of the market. Taysha Gene Therapies Inc share today touched a day high of $3.12 and a low of $2.91.
Taysha Gene Therapies Inc share touched a 52 week high of $3.4 on and a 52 week low of $1.05 on . Taysha Gene Therapies Inc stock price today i.e. is closed at $3.02,which is 11.18% down from its 52 week high and 187.62% up from its 52 week low.
Taysha Gene Therapies Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Taysha Gene Therapies Inc (TSHA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Taysha Gene Therapies Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Taysha Gene Therapies Inc share’s latest price of $3.02 as on September 16, 2025 at 1:29 am IST, you will get 3.3113 shares of Taysha Gene Therapies Inc. Learn more about
fractional shares .